Endogenous Galectin-9 Suppresses Apoptosis in Human Rheumatoid Arthritis Synovial Fibroblasts. 2018

Mark J Pearson, and Magdalena A Bik, and Caroline Ospelt, and Amy J Naylor, and Corinna Wehmeyer, and Simon W Jones, and Christopher D Buckley, and Steffen Gay, and Andrew Filer, and Janet M Lord
Aston Medical School, Aston University, Birmingham, B4 7ET, UK.

Galectin-9 (Gal9) has been postulated to have anti-inflammatory properties based on the ability of exogenous Gal9 to induce apoptosis in synovial fibroblasts in animal models of rheumatoid arthritis (RA). Here we aimed to assess the potential role of endogenous Galectins, including Gal9, in the inflammatory pathology of the RA synovium in humans. Firstly expression of Galectins 1-9 was determined in synovial fibroblasts (RASF) and dermal fibroblasts (DF) isolated from RA patients, the latter representing a non-inflamed site. We then further challenged the cells with pro-inflammatory TLR agonists and cytokines and assessed Galectin expression. Gal9 was found to be differentially and abundantly expressed in RASF compared to DF. Agonists of TLR3 and TLR4, along with IFNgamma were also found to induce Gal9 expression in RASF. siRNA was then used to knock-down Gal9 expression in RASF and the effects of this on apoptosis and cell viability were assessed. Increased apoptosis was observed in RASF following Gal9 knock-down. We conclude that, unlike exogenous Gal9, endogenous Gal9 is protective against apoptosis and enhances synovial fibroblast viability suggesting that its role in RA is both pathogenic and pro-inflammatory.

UI MeSH Term Description Entries
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D013583 Synovial Membrane The inner membrane of a joint capsule surrounding a freely movable joint. It is loosely attached to the external fibrous capsule and secretes SYNOVIAL FLUID. Synovium,Membrana Synovialis Capsulae Articularis,Membrane, Synovial,Membranes, Synovial,Synovial Membranes
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D015870 Gene Expression The phenotypic manifestation of a gene or genes by the processes of GENETIC TRANSCRIPTION and GENETIC TRANSLATION. Expression, Gene,Expressions, Gene,Gene Expressions
D016207 Cytokines Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner. Cytokine
D020868 Gene Silencing Interruption or suppression of the expression of a gene at transcriptional or translational levels. Gene Inactivation,Inactivation, Gene,Silencing, Gene

Related Publications

Mark J Pearson, and Magdalena A Bik, and Caroline Ospelt, and Amy J Naylor, and Corinna Wehmeyer, and Simon W Jones, and Christopher D Buckley, and Steffen Gay, and Andrew Filer, and Janet M Lord
December 2007, Arthritis and rheumatism,
Mark J Pearson, and Magdalena A Bik, and Caroline Ospelt, and Amy J Naylor, and Corinna Wehmeyer, and Simon W Jones, and Christopher D Buckley, and Steffen Gay, and Andrew Filer, and Janet M Lord
July 2003, Journal of immunology (Baltimore, Md. : 1950),
Mark J Pearson, and Magdalena A Bik, and Caroline Ospelt, and Amy J Naylor, and Corinna Wehmeyer, and Simon W Jones, and Christopher D Buckley, and Steffen Gay, and Andrew Filer, and Janet M Lord
July 2006, Annals of the rheumatic diseases,
Mark J Pearson, and Magdalena A Bik, and Caroline Ospelt, and Amy J Naylor, and Corinna Wehmeyer, and Simon W Jones, and Christopher D Buckley, and Steffen Gay, and Andrew Filer, and Janet M Lord
July 2014, Molecular medicine reports,
Mark J Pearson, and Magdalena A Bik, and Caroline Ospelt, and Amy J Naylor, and Corinna Wehmeyer, and Simon W Jones, and Christopher D Buckley, and Steffen Gay, and Andrew Filer, and Janet M Lord
January 2015, Current pharmaceutical design,
Mark J Pearson, and Magdalena A Bik, and Caroline Ospelt, and Amy J Naylor, and Corinna Wehmeyer, and Simon W Jones, and Christopher D Buckley, and Steffen Gay, and Andrew Filer, and Janet M Lord
May 2009, Nature reviews. Rheumatology,
Mark J Pearson, and Magdalena A Bik, and Caroline Ospelt, and Amy J Naylor, and Corinna Wehmeyer, and Simon W Jones, and Christopher D Buckley, and Steffen Gay, and Andrew Filer, and Janet M Lord
May 2000, Annals of the rheumatic diseases,
Mark J Pearson, and Magdalena A Bik, and Caroline Ospelt, and Amy J Naylor, and Corinna Wehmeyer, and Simon W Jones, and Christopher D Buckley, and Steffen Gay, and Andrew Filer, and Janet M Lord
June 1995, Annals of the rheumatic diseases,
Mark J Pearson, and Magdalena A Bik, and Caroline Ospelt, and Amy J Naylor, and Corinna Wehmeyer, and Simon W Jones, and Christopher D Buckley, and Steffen Gay, and Andrew Filer, and Janet M Lord
August 2016, Zeitschrift fur Rheumatologie,
Mark J Pearson, and Magdalena A Bik, and Caroline Ospelt, and Amy J Naylor, and Corinna Wehmeyer, and Simon W Jones, and Christopher D Buckley, and Steffen Gay, and Andrew Filer, and Janet M Lord
December 2009, Arthritis and rheumatism,
Copied contents to your clipboard!